420 investor

Halloween is prime spooky season, but for most investors, all of 2022 has been quite scary. Stocks across the board have taken substantial hits this year, with cannabis particularly affected. Cannabis' surging pandemic performances have been dashed mostly. Now, Fed uncertainty looms while...

Sales growth in Canada appears to be stagnating for the cannabis sector. Statistics Canada released August retail sales for the country reporting that cannabis sales increased from July by 0.2% to CA$393.7 million ($288 million). In August, sales increased 13.0% from one year earlier, down...

Cannabis experienced a bit of a setback in 2021, with sales dipping in many major U.S. markets compared to the staggering results of the year prior, setting the stage for a new year of potential opportunity and uncertainty.  "This year will be a telling sign on the industry, as many are...

No longer reeling from a bear market, the American cannabis industry appears poised to continue its growth throughout 2021. Some states stand out to investors more than others due to strong performances and first-year potential. According to Headset Data Analyst Cooper Ashley, sales from...

Alan Brochstein, author of 420 Investor and founding partner of New Cannabis Ventures, says the recent political momentum behind the cannabis legalization push in the US — and the resulting rebound in cannabis stocks since the U.S. election — has him feeling extremely optimistic...

Florida's $750 million medical marijuana market is slated to experience another wave of growth now that the state's Department of Health (DOH) has permitted the sale of edibles — with certain rules. A Conservative Approach Kim Rivers, CEO of Trulieve Cannabis...

July figures from Marijuana Business Daily suggest the United States cannabis market could have an economic impact of $130 billion by 2024. As the licensed market grows, so too does the focus on federal adult-use laws. While nothing appears imminent at the moment, the various bills making...

As shelter-in-place orders drag on and the U.S. economy limps through the second quarter, investors, economists and politicians are asking important questions about what the post-outbreak economy will look like and how quickly the U.S. can replace the 26 million jobs it has lost in 2020. Many...

Alan Brochstein, founder of 420 Investor and New Cannabis Ventures, joined Benzinga’s PreMarket Prep show Monday to discuss how the cannabis industry and its main players are navigating the looming recession. In recent weeks, some financial commentators have viewed the recent...

It has been a brutal couple of years for cannabis investors. With most leading stocks down even further since the COVID-19 outbreak, cannabis investors are now weighing whether to cut their losses or buy the dip in a bet on a rebound ahead. Alan Brochstein, author of the 420 Investor and founding...

It has been a brutal year for cannabis investors. Heading into 2020, cannabis investors are now weighing whether to cut their losses or buy the dip in a bet on a rebound ahead. Alan Brochstein, author of the 420 Investor and founding partner of New Cannabis Ventures, recently discussed his outlook...

Thursday marked the one-year anniversary of the legalization of recreational marijuana in Canada. Legalization hasn't translated into the end of the illicit market, and the price differences between the legal and illegal markets are substantial.  Legally accredited cannabis...

"420 Investor" Alan Brochstein has a simple message to CannTrust Holdings Inc (NYSE: CTC) CEO Peter Aceto: apologize for violating Health Canada rules and resign. What Happened CannTrust said in a press release Monday that it "accepted" a Health Canada finding that some of its...

The week brought big cannabis news, with the FDA setting its first hearing regarding CBD's legality in food and drinks for May, and the STATES Act, which aims to protect cannabis businesses and users in legal states from federal intervention, being introduced in Congress. “Allowing...

Alan Brochstein, author of "420 Investor" and founding partner of New Cannabis Ventures, appeared on Benzinga's PreMarket Prep show Friday morning and explained why he likes Alcanna Inc (OTC: LQSIF). What Happened Brochstein discussed why Alcanna, a Western Canada-based retailer of...